TR201720293A2 - Tolperisone and non-selective cox inhibitor combinations - Google Patents

Tolperisone and non-selective cox inhibitor combinations Download PDF

Info

Publication number
TR201720293A2
TR201720293A2 TR2017/20293A TR201720293A TR201720293A2 TR 201720293 A2 TR201720293 A2 TR 201720293A2 TR 2017/20293 A TR2017/20293 A TR 2017/20293A TR 201720293 A TR201720293 A TR 201720293A TR 201720293 A2 TR201720293 A2 TR 201720293A2
Authority
TR
Turkey
Prior art keywords
tolperisone
selective cox
cox inhibitor
inhibitor combinations
pharmaceutically acceptable
Prior art date
Application number
TR2017/20293A
Other languages
Turkish (tr)
Inventor
Türkkan Seyhan
Türkyilmaz Ali̇
Pehli̇van Akalin Nur
Misirli Melda
Tuncay Emi̇ne
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2017/20293A priority Critical patent/TR201720293A2/en
Priority to EP18911384.8A priority patent/EP3723735A4/en
Priority to PCT/TR2018/050801 priority patent/WO2019190432A2/en
Publication of TR201720293A2 publication Critical patent/TR201720293A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to pharmaceutical combinations comprising tolperisone or a pharmaceutically acceptable salt, solvate, polymorph, isomer, enantiomer or rasemic mixture thereof and non-selective COX inhibitors or pharmaceutically acceptable salts, solvates, polymorphs, isomers, enantiomers or rasemic mixtures thereof.
TR2017/20293A 2017-12-13 2017-12-13 Tolperisone and non-selective cox inhibitor combinations TR201720293A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2017/20293A TR201720293A2 (en) 2017-12-13 2017-12-13 Tolperisone and non-selective cox inhibitor combinations
EP18911384.8A EP3723735A4 (en) 2017-12-13 2018-12-12 Tolperisone and non-selective cox inhibitor combinations
PCT/TR2018/050801 WO2019190432A2 (en) 2017-12-13 2018-12-12 Tolperisone and non-selective cox inhibitor combinations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/20293A TR201720293A2 (en) 2017-12-13 2017-12-13 Tolperisone and non-selective cox inhibitor combinations

Publications (1)

Publication Number Publication Date
TR201720293A2 true TR201720293A2 (en) 2019-06-21

Family

ID=67952207

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2017/20293A TR201720293A2 (en) 2017-12-13 2017-12-13 Tolperisone and non-selective cox inhibitor combinations

Country Status (3)

Country Link
EP (1) EP3723735A4 (en)
TR (1) TR201720293A2 (en)
WO (1) WO2019190432A2 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040204413A1 (en) 2001-01-26 2004-10-14 Joaquina Faour Pharmaceutical compositions containing a COX-II inhibitor and a muscle relaxant
HUP0700828A2 (en) 2007-12-20 2010-01-28 Richter Gedeon Nyrt Transdermal pharmaceutical compositions containing tolperisone alone and in combination
EA201171109A1 (en) * 2009-03-09 2012-03-30 Динеш Шантилал Пател NEW COMPOSITION OF THE DELAYED RELEASE OF COMPOUNDS SELECTED FROM THE CLASS OF MINORALEXANTS OF CENTRAL ACTION

Also Published As

Publication number Publication date
WO2019190432A3 (en) 2019-11-21
EP3723735A2 (en) 2020-10-21
WO2019190432A2 (en) 2019-10-03
EP3723735A4 (en) 2021-11-10

Similar Documents

Publication Publication Date Title
PH12018501179A1 (en) Compounds and methods for kinase modulation, and indications therefor
WO2017019804A3 (en) Compounds and methods for kinase modulation, and indications therefor
PH12018501099A1 (en) Novel biphenyl compound or salt thereof
PH12016502255A1 (en) Combination
MA40059A (en) Phosphatidylinositol 3-kinase inhibitors
MX2018003284A (en) Antifungal compounds and processes for making.
CL2020000610A1 (en) Bisamide compounds that activate the sarcomere and their uses.
PH12017501523A1 (en) Selective bace1 inhibitors
CY1121746T1 (en) TETRAZOLONE-DIHYDROPYRIDINONE SUBSTITUTED MGAT2 INHIBITORS
AR098870A1 (en) Polymorphic forms of a chlorohydrate salt of (S) -2- (1- (9H-PURIN-6-ILAMINO) PROPIL) -5-FLUORO-3-PHENYLQUINAZOLIN-4 (3H) -ONA
MX2020003020A (en) Aminocarbonylcarbamate compounds.
MX364901B (en) Pharmaceutical antiretroviral composition.
SA520411406B1 (en) Lysophosphatidic acid receptor 1 inhibitor compounds
CU20160166A7 (en) COMPOUNDS DERIVED FROM N- (1,5-DIMETIL-3-OXO-2,3-DIHIDRO-1H-PIRAZOL-4-IL) -4-METHYL-5-ISOXAZOL-3-CARBOXAMIDE AS SELECTIVE INHIBITORS OF SMURF-1
EA201892235A1 (en) GRANULAR COMPOSITION FOR ORAL APPLICATION
MX2019002065A (en) Triazolopyrazinone derivative useful as a human pde1 inhibitor.
WO2019203751A3 (en) Tolperisone and selective cox-2 inhibitor combinations
EA201891688A1 (en) ADAMANTAN DERIVATIVE AND ITS APPLICATION
TR201720293A2 (en) Tolperisone and non-selective cox inhibitor combinations
ECSP18023544A (en) FORMULATIONS OF 3- (5-AMINO-2-METHYL-4-OXO-4H-QUINAZOLIN-3-IL) -PIPERIDIN-2,6-DIONA
WO2020086038A3 (en) Topical compositions comprising tolperisone and selective cox-2 inhibitor combination
WO2020086046A3 (en) Topical compositions comprising tolperisone and flurbiprofen combination
AR105923A1 (en) THERAPEUTIC COMPOUNDS FOR PAIN AND SYNTHESIS OF THESE
EA201992192A1 (en) CAPA-OPIOID RECEPTOR ANTAGONISTS AND RELATED PRODUCTS AND METHODS
GB201714447D0 (en) Drug intermediates 3,5-dimethoxybenzaldehyde synthesis method